| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 28.875 | 28.004 | 35.222 | 52.988 | 39.127 | 37.367 | 25.529 | 60.830 | 66.168 | 86.441 |
| Total Income - EUR | 28.875 | 28.004 | 35.222 | 52.988 | 39.127 | 37.367 | 25.529 | 60.830 | 66.305 | 87.509 |
| Total Expenses - EUR | 21.494 | 25.192 | 33.454 | 38.822 | 39.971 | 31.514 | 29.581 | 54.695 | 69.635 | 67.313 |
| Gross Profit/Loss - EUR | 7.381 | 2.813 | 1.769 | 14.167 | -844 | 5.853 | -4.052 | 6.135 | -3.330 | 20.196 |
| Net Profit/Loss - EUR | 6.515 | 2.253 | 1.417 | 13.638 | -1.236 | 5.480 | -4.307 | 5.527 | -3.993 | 17.915 |
| Employees | 2 | 2 | 3 | 3 | 3 | 3 | 2 | 4 | 4 | 2 |
Check the financial reports for the company - Ana-Dor-Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 1.492 | 3.139 | 1.737 | 11.316 | 9.951 | 17.317 | 12.230 | 19.083 | 15.072 | 20.080 |
| Inventories | 1.013 | 2.739 | 1.230 | 32 | 1.686 | 2.978 | 7.346 | 3.896 | 10.058 | 6.552 |
| Receivables | 44 | 43 | 42 | 42 | 89 | 87 | 85 | 46 | 684 | 680 |
| Cash | 435 | 357 | 464 | 11.243 | 8.176 | 14.252 | 4.798 | 15.141 | 4.331 | 12.848 |
| Shareholders Funds | -7.341 | -5.014 | -3.512 | 10.190 | 8.757 | 14.071 | 9.452 | 15.008 | 10.970 | 18.092 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 8.833 | 8.153 | 5.249 | 1.126 | 1.194 | 3.246 | 2.778 | 4.075 | 4.102 | 1.988 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "5610 - 5610" | |||||||||
| CAEN Financial Year |
5610
|
|||||||||
Comments - Ana-Dor-Med S.r.l.